Additional file 2: Table S2. of Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case–control study with digital mammography

Univariate logistic regression tables for absolute area, absolute volume, VD %, and BI-RADS breast density adjusted for both standard risk factors and BMI. BI-RADS Breast Imaging-Reporting and Data System, BMI body mass index, LIBRA Laboratory for Individualized Breast Radiodensity Assessment, N/A not applicable, VD % volume percent density. (PDF 213 kb

Additional file 1: Table S1. of Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case–control study with digital mammography

Univariate logistic regression tables for absolute area, absolute volume, VD %, and BI-RADS breast density adjusted for standard risk factors. BI-RADS Breast Imaging-Reporting and Data System, LIBRA Laboratory for Individualized Breast Radiodensity Assessment, N/A not applicable, VD % volume percent density. (PDF 207 kb

Survival curves for subgroups stratified by top predictive features.

(30-day mortality: Physiologic high-risk factors, elective surgery, functional status, HCT, and creatinine, 30-day unplanned readmission: Open wound/wound infection, major reintervention of treated arterial segment, elective surgery, claudication, and diabetes). (TIF)</p

Gini impurity and SHAP scores for mortality.

a) Gini impurity scores for features included in the 30-day mortality model. Higher values indicate increased effectiveness of features at separating those at risk of 30-day mortality from those not at risk of 30-day mortality. b) A Shapley summary plot. Color indicates feature value (red: High, blue: Low) and position.</p

Performance metrics of all readmission models on the testing set.

Performance metrics of all readmission models on the testing set.</p

Variables used for model development.

(PDF)</p

Fig 2 -

Receiver-operating characteristic curves for a) 30-day mortality and b) 30-day unplanned readmission models.</p

Flow chart illustrating the phases of model development.

Flow chart illustrating the phases of model development.</p

CPT codes of cases extracted from the ACS-NSQIP database.

(PDF)</p

Performance metrics of all models on the testing set.

Performance metrics of all models on the testing set.</p